arrow
S

Stefano Costa

policlinico universitario "g martino"
H指数:20
被引数:1,439

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mutations with residual CFTR function are associated with better glucose tolerance and insulin secretion in people with Cystic fibrosis

具有残余CFTR功能的突变与囊性纤维化患者中更好的葡萄糖耐受性和胰岛素分泌相关。

2025-11-140
OAAI
Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR

超越Trikafta:评估组织依赖性N1303K-CFTR挽救的新模型

2025-10-290
OAAI
Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 years with Cystic Fibrosis and at Least one F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor ( vol 274, 114176, 2024)
2024-11-010
PRE
Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor
2024-11-015
PRE
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study
2023-11-0921
OAAI
Rescue by elexacaf tor-tezacaf tor-ivacaf tor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background

G1244E囊性纤维化突变的稳定性和门控缺陷依赖于细胞背景

2023-05-0116
PRE
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the iMAging managEment of cySTic fibROsis (MAESTRO) consortium
2022-03-2325
OAAI
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial
2021-02-01123
OAAI
Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial
2018-05-0131
OAAI
IROA: International Register of Open Abdomen, preliminary results (vol 12, pg 13, 2017)
2017-03-091
OAAI
IROA: International Register of Open Abdomen, preliminary results
2017-02-2153
OAAI